Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, ca... Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The firm sells its products globally, with the United States representing close to one third of total revenue. Show more
Intel (NASDAQ:INTC) – Intel secured up to $3.5 billion in federal subsidies to manufacture semiconductors for the U.S. Department of Defense. This information was disclosed by Bloomberg...
The urgent need for innovative technologies to accelerate the development of life-saving cancer therapies has never been more critical. With millions of lives and billions of To read the full...
LEXINGTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that...
Novartis si assicura i diritti esclusivi globali alla tecnologia di microglassification di Lindy Biosciences in diversi target biologici La collaborazione mira a consentire trattamenti...
Novartis obtient les droits mondiaux exclusifs sur la technologie de microglassification de Lindy Biosciences pour de multiples cibles biologiques Cette collaboration vise à permettre des...
Novartis sichert sich die weltweiten Exklusivrechte an der Mikroverglasungstechnologie von Lindy Biosciences für mehrere biologische Zielmoleküle Die Zusammenarbeit zielt darauf ab...
Novartis secures exclusive global rights across multiple biologic targets to Lindy Biosciences' microglassification technology Collaboration aims to enable high-concentration self-administered...
International Business Machines (NYSE:IBM) – According to the South China Morning Post, IBM has closed its R&D operations in China, laying off over 1,000 employees due to geopolitical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.03 | -0.883058984911 | 116.64 | 116.945 | 114.91 | 1002404 | 116.17444241 | DR |
4 | -4.74 | -3.93851267138 | 120.35 | 120.92 | 113.82 | 1102659 | 116.68393966 | DR |
12 | 7.43 | 6.86818265853 | 108.18 | 120.92 | 105.72 | 1210883 | 112.98195559 | DR |
26 | 20.11 | 21.057591623 | 95.5 | 120.92 | 92.35 | 1359301 | 105.31005124 | DR |
52 | 14.32 | 14.1376246421 | 101.29 | 120.92 | 92.19 | 1444560 | 102.11790839 | DR |
156 | 33.11 | 40.1333333333 | 82.5 | 120.92 | 74.09 | 1934224 | 91.35609151 | DR |
260 | 28.63 | 32.9156127845 | 86.98 | 120.92 | 69.1 | 1946325 | 90.00489132 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.